Peter Radovich - Jan 7, 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
PRESIDENT AND COO
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jan 7, 2025
Transactions value $
-$85,545
Form type
4
Date filed
1/8/2025, 04:44 PM
Previous filing
Mar 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$85.5K -2K -6.89% $42.82 27K Jan 7, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.